Use of Flt3 ligand to evaluate residual hematopoiesis after heterogeneous irradiation in mice

Radiation Research

Volumn 166, Issue 3, 2006, Pages 504-511

  Prat, Marie ^a,b   Demarquay, Christelle ^a,b   Frick, Johanna ^a,b   Dudoignon, Nicolas ^a   Thierry, Dominique ^a,b   Bertho, Jean Marc ^a,b  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW APLASIA; CONTROLLED STUDY; HEMATOPOIESIS; IRRADIATION; MALE; MOUSE; NONHUMAN; NONLINEAR REGRESSION ANALYSIS; PANCYTOPENIA; PRIORITY JOURNAL; RADIATION DOSE;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEMATOPOIESIS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; RADIATION DOSAGE; STATISTICS; WHOLE-BODY IRRADIATION;

EID: 33748450688     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0568.1     Document Type: Article

References (30)

1. T. M. Fliedner, B. Tibken, E. P. Hofer and W. Paul, Stem cell responses after radiation exposure: A key to the evaluation and prediction of its effects. Health Phys. 70, 787-797 (1996).
2. L. J. Cole, H. M. Haire and E. L. Alpen, Partial shielding of dogs: Effectiveness of small external epicondylar lead cuffs against lethal X-radiation. Radiat. Res. 32, 54-63 (1967).
3. J. D. Down, A. Boudewijn, R. van Os, H. D. Thames and R. E. Ploemacher, Variations in radiation sensitivity and repair among different hematopoietic stem cell subsets following fractionated irradiation. Blood 86, 122-127 (1995).
4. C. T. Jordan and I. R. Lemischka, Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 4, 220-232 (1990).
5. N. C. Parmentier, J. C. Nénot and H. J. Jammet, A dosimetric study of the Belgian (1965) and Italian (1975) accidents. In The Medical Basis for Radiation Accident Preparedness (K. F. Hübner and S. A. Fry, Eds.), pp. 105-112. Elsevier, Amsterdam, 1980.
6. A. E. Baranov, G. D. Selidovkin, A. Butturini and R. P. Gale, Hematopoietic recovery after 10-Gy acute total body radiation. Blood 83, 596-599 (1994).
7. H. Nagayama, K. Misawa, H. Tanaka, J. Ooi, T. Iseki, A. Tojo, K. Tani, Y. Yamada, H. Kodo and S. Asano, Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim. Bone. Marrow Transpl. 29, 197-204 (2002).
8. IAEA, Cytogenetic Analysis for Dose Assessment: A Manual. Technical reports series no. 405. International Atomic Energy Agency, Vienna, 2001.
9. G. Silini and A. Gouskova, Biological dosimetry at Chernobyl. In New Horizons in Biological Dosimetry (B. L. Gledhill and F. Mauro, Eds.), pp. 129-144. Wiley-Liss, New York, 1991.
10. A. Wodnar-Filipowicz, S. D. Lyman, A. Gratwohl, A. Tichelli, B. Speck and C. Nissen, Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 88, 4493-4499 (1996).
11. J. M. Bertho, C. Demarquay, J. Frick, C. Joubert, S. Arenales, N. Jacquet, I. Sorokine-Durm, Q. Chau, M. Lopez and P. Gourmelon, Level of Flt3 ligand in plasma: A possible new bio-indicator for radiation-induced aplasia. Int. J. Radiat. Biol. 77, 703-712 (2001).
12. A. Huchet, Y. Belkacemi, J. Frick, M. Prat, I. Muresan-Kloos, D. Altan, A. Chapel, N. C. Gorin and J. M. Bertho, Plasma Flt-3 ligand concentration correlated with radiation-induced bone marrow damage during local fractionated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 508-515 (2003).
13. R. D. Blumenthal, W. Lew, M. Juweid, R. Alisaukas, Z. Ying and D. M. Goldberg, Plasma Flt3-L levels predict bone marrow recovery from myelosuppressive therapy. Cancer 88, 333-343 (2000).
14. D. R. Boggs, The total marrow mass of the mouse: A simplified method of measurement. Am. J. Hematol. 16, 277-286 (1984).
15. M. Prat, C. Demarquay, J. Frick, D. Thierry, N. C. Gorin and J. M. Bertho, Radiation-induced increase in plasma Flt3 ligand concentration in mice: Evidence for the implication of several cell types. Radiat. Res. 163, 408-417 (2005).
16. S. D. Lyman, L. James, L. Johnson, K. Brasel, P. de Vries, S. S. Escobar, H. Downey, R. R. Splett, M. P. Beckmann and H. J. McKenna, Cloning of the human homologue of the murine Flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83, 2795-2801 (1994).
17. C. Hannum, J. Culpepper, D. Campbell, T. McClanahan, S. Zurawski, J. F. Bazan, R. Kastelein, S. Hudak, J. Wagner and F. Lee, Ligand for Flt3/Flk2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNA. Nature 368, 643-648 (1994).
18. S. Fichelson, The Flt3/Flk2 ligand: Structure, functions and prospects. Eur. Cytokine Netw. 9, 7-22 (2000).
19. S. D. Lyman, M. Seaberg, R. Hanna, J. Zappone, K. Brasel, J. L. Abkowitz, J. I. Prchal, J. C. Schultz and N. T. Shahidi, Plasma/serum levels of Flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood 86, 4091-4096 (1995).
20. J. M. Bertho, J. Frick, M. Prat, C. Demarquay, N. Dudoignon, F. Trompier, N. C. Gorin, D. Thierry and P. Gourmelon, Comparison of autologous cell therapy and granulocyte-colony stimulating factor (G-CSF) injection vs. G-CSF injection alone for the treatment of acute radiation syndrome in a non human primate model. Int. J. Radiat. Oncol. Biol. Phys. 63, 911-920 (2005).
21. M. Prat, J. Frick, J. Ph. Laporte, D. Thierry, N. C. Gorin and J. M. Bertho, Kinetics of plasma Flt3 ligand concentration in hematopoietic stem cell transplanted patients. Leuk. Lymphoma 47, 77-80 (2006).
22. J. A. Siegel, D. Yeldell, D. M. Goldenberg, M. G. Stabin, R. B. Sparks, R. M. Sharkey, A. Brenner and R. D. Blumenthal, Red marrow radiation dose adjustment using plasma Flt3 ligand cytokine levels: Improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients. J. Nucl. Med. 44, 67-76 (2003).
23. G. W. Dolphin, Biological dosimetry with particular reference to chromosome aberration analysis. A review of methods. In Handling of Radiation Accidents, pp. 215-224. International Atomic Energy Agency, Vienna, 1969.
24. H. P. Jammet, R. Gongora, R. Le Go, G. Marble and M. Faes, Observation clinique et traitement d'un cas d'irradiation globale accidentelle. In First IRPA Congress, Vol. 2, Session B, pp. 1249-1291. International Radiation Protection Association, Rome, 1966. [Available online at http://www2000.irpa. net/pub/pr/index.html7page. html%3Fil_volume_2.html%7Eftopic_pubpr~fpage_pubpr]
25. T. Hirama, S. Tanosaki, S. Kandatsu, N. Kuroiwa, T. Kamada, H. Tsuji, S. Yamada, H. Katoh, N. Yamamoto and M. Akashi, Initial medical management of patients severely irradiated in the Tokaimura criticality accident. Br. J. Radiol. 76, 246-253 (2003).
26. F. Varas, A. Bernard and J. A. Bueren, Granulocyte colony-stimulating factor mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice. Blood 88, 2495-2501 (1996).
27. T. Grande and J. A. Bueren, A new approach to evaluate the total reserve of hematopoietic progenitors after acute irradiation. Radiat. Res. 162, 397-404 (2004).
28. T. M. Fliedner, I. Frieseke and K. Beyrers, The Medical Management of Radiation Accidents, Manual on the Acute Radiation Syndrome. British Institute of Radiology, Oxford, 2001.
29. J. P. Jouet, N. C. Gorin and P. Gourmelon, Gestion médicale des victimes d'irradiation lors d'un accident nucléaire ou d'un acte de malveillance de grande ampleur. In Les entretiens de Bichat, Tables rondes thérapeutiques, pp. 144-147. Expansion Scientifique Française, Paris, 2003.
30. J. M. Bertho, J. Frick, D. Demarquay, A. Lauby, E. Mathieu, N. Dudoignon, N. Jacquet, Q. Chau, C. Joubert and D. Thierry, Reinjection of ex vivo expanded primate bone marrow mononuclear cells strongly reduces radiation-induced aplasia. J. Hematother. Stem Cell Res. 11, 549-564 (2002).